Respiratory Infections News

A cell-based influenza vaccine was 54% effective among children during three recent influenza seasons and provided protection regardless of previous vaccination status, according to the results of a randomized clinical trial.

Pregnant women who had symptomatic SARS-CoV-2 infection were more likely than those with asymptomatic infection to have an emergency delivery, and their infants more often experienced adverse outcomes, a recent study showed.

The use of interferon gamma release assays can reduce overdiagnosis of latent tuberculosis infection among people from countries that use the bacille Calmette-Guérin vaccine and have moderate to high rates of disease, according to a study.

The risk for a breakthrough SARS-CoV-2 infection was significantly higher among patients with a substance use disorder than those without one, a population-based cohort study showed.

Merck and Ridgeback Biotherapeutics have announced that they submitted an emergency use authorization application to the FDA for molnupiravir, an oral antiviral that “inhibits the replication of SARS-CoV-2.”

Researchers may have found a way to predict the severity of COVID-19 infection in children by examining their saliva, according to a multi-institutional study presented at the AAP National Conference & Exhibition.

The antibody cocktail of casirivimab and imdevimab significantly reduced viral loads in hospitalized patients with COVID-19 who were receiving low-flow or no supplemental oxygen, data presented at IDWeek showed.

AstraZeneca this week submitted an emergency use authorization request to the FDA for AZD7442, a long-acting monoclonal antibody cocktail to be used for pre-exposure prophylaxis for symptomatic COVID-19 in adults.

COVID-19 mitigation efforts prevented the spread of influenza and respiratory syncytial virus by almost 100% in northern Ohio, according to research presented at the American Academy of Pediatrics National Conference & Exhibition.

Although nearly 70% of U.S. adults said last year’s mild influenza season will not impact their decision to get a vaccine this year, many indicated they would continue pandemic-related precautions through the season, a survey found.